Nobelis Group anti-aging cream black pot
Nobelis Group anti-aging cream black pot
Couldn't load pickup availability
Lierac Premium Silky Anti-Aging Moisturizing Cream 50ml offers a delicate, melting texture, suitable for mature skin seeking comfort and daily hydration. This treatment targets the visible signs of skin aging and is part of a beauty routine to strengthen the skin barrier and preserve the skin's natural radiance.
- Intensely hydrates the skin.
- Contributes to the feeling of skin comfort.
Apply a small amount of cream morning and/or evening to clean, dry skin on the face and neck, avoiding the eye area. Massage in gently in circular motions until completely absorbed.
Aqua (Water), Glycerin, Caprylic/Capric Triglyceride, Butyrospermum Parkii (Shea) Butter, Dimethicone, Cetearyl Alcohol, Propanediol, Hydrogenated Polyisobutene, Cetyl Alcohol, Cetearyl Glucoside, Parfum (Fragrance), Phenoxyethanol, Sodium Polyacrylate, Sodium Hyaluronate, Peg-8, Disodium Edta, Tocopherol, Lecithin, Ascorbyl Palmitate, Citric Acid, Polysorbate 20, Sorbitan Oleate, CI 19140 (Yellow 5), CI 16035 (Red 40). For the full list of ingredients, see package insert.
Legal notices:
The information on this product sheet is provided for information purposes only, in accordance with Regulation (EC) No. 1924/2006 on nutrition and health claims made on foodstuffs, and Article L. 111-1 of the French Consumer Code.
They cannot in any case constitute a medical prescription nor replace the consultation of a qualified health professional. Any use of the product must comply with the instructions, the recommended dosage, and the precautions for use.
In accordance with Article L. 5122-15 of the Public Health Code, the distributor cannot be held liable in the event of misuse, self-medication or non-compliance with official recommendations.
Photographs, descriptions, and technical information are non-contractual and are subject to change at any time. The user is encouraged to regularly check for updates or contact a healthcare professional for any treatment-related questions.
